|
|
|
Insider
Information: |
Ivers-Read Gillian C |
Relationship: |
See Remarks |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
293,612 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
293,612 |
|
|
Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
27
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
24
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,222.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-06-22 |
4 |
S |
$6.74 |
$5,587 |
D/D |
(829) |
208,855 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-09-21 |
4 |
S |
$6.85 |
$5,740 |
D/D |
(838) |
212,731 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-06-03 |
4 |
S |
$7.03 |
$4,204 |
D/D |
(598) |
207,809 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-03-03 |
4 |
S |
$7.20 |
$4,356 |
D/D |
(605) |
203,775 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-02-02 |
4 |
S |
$7.97 |
$87,590 |
D/D |
(10,990) |
244,346 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-05-05 |
4 |
S |
$8.10 |
$11,948 |
D/D |
(1,475) |
207,095 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
S |
$8.41 |
$60,586 |
D/D |
(7,204) |
203,067 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-12-20 |
4 |
S |
$11.30 |
$9,379 |
D/D |
(830) |
195,274 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2011-11-21 |
4 |
B |
$13.00 |
$69,199 |
D/D |
5,323 |
218,583 |
2.74 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-12-03 |
4 |
S |
$14.59 |
$8,640 |
D/D |
(592) |
194,229 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-06-20 |
4 |
S |
$14.70 |
$12,186 |
D/D |
(829) |
191,788 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-06-04 |
4 |
S |
$15.07 |
$8,695 |
D/D |
(577) |
190,742 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-20 |
4 |
S |
$17.72 |
$14,690 |
D/D |
(829) |
187,198 |
0 |
- |
|
WTKND |
Welltek Incorporated |
officerTitle |
|
2005-12-13 |
4 |
S |
$18.37 |
$140,787 |
D/D |
(7,650) |
0 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-04 |
4 |
S |
$21.23 |
$5,308 |
D/D |
(250) |
186,152 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-20 |
4 |
S |
$26.13 |
$21,688 |
D/D |
(830) |
190,007 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-05 |
4 |
S |
$29.29 |
$47,186 |
D/D |
(1,611) |
188,962 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-20 |
4 |
D |
$32.21 |
$26,702 |
D/D |
(829) |
185,777 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-05 |
4 |
D |
$35.75 |
$10,082 |
D/D |
(282) |
184,731 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-08-24 |
4 |
S |
$38.50 |
$918,292 |
D/D |
(23,840) |
10,176 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Vice President |
|
2004-12-09 |
4 |
S |
$45.50 |
$1,422,545 |
D/D |
(31,250) |
0 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-20 |
4 |
D |
$45.75 |
$37,927 |
D/D |
(829) |
184,388 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-05-15 |
4 |
AS |
$47.39 |
$142,170 |
D/D |
(3,000) |
203,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-06 |
4 |
D |
$47.70 |
$13,261 |
D/D |
(278) |
183,342 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-02-15 |
4 |
AS |
$54.09 |
$162,270 |
D/D |
(3,000) |
180,571 |
0 |
- |
|
117 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|